MedPath

宁夏启元医药有限公司

Ownership
-
Established
2001-11-22
Employees
-
Market Cap
-
Website
http://www.china-qiyuan.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

321

NMPA:321

Drug Approvals

山楂精降脂分散片

Approval Number
国药准字Z20090859
Approval Date
Apr 7, 2024
NMPA

银黄胶囊

Approval Number
国药准字Z20093452
Approval Date
Apr 7, 2024
NMPA

金莲清热胶囊

Approval Number
国药准字Z20080081
Approval Date
Mar 16, 2023
NMPA

脑灵素片

Approval Number
国药准字Z20073108
Approval Date
Apr 2, 2022
NMPA

防风通圣丸

Approval Number
国药准字Z20064416
Approval Date
May 26, 2021
NMPA

Atropine Sulfate Tablets

Product Name
硫酸阿托品片
Approval Number
国药准字H64020121
Approval Date
Dec 18, 2019
NMPA

Berberine Hydrochloride and Trimethoprim Capsules

Product Name
小檗碱甲氧苄啶胶囊
Approval Number
国药准字H64020251
Approval Date
Dec 18, 2019
NMPA

Benproperine Phosphate Tablets

Product Name
磷酸苯丙哌林片
Approval Number
国药准字H64020084
Approval Date
Dec 18, 2019
NMPA

Aspirin Enteric-coated Tablets

Product Name
阿司匹林肠溶片
Approval Number
国药准字H64020232
Approval Date
Dec 18, 2019
NMPA

Ranitidine Hydrochloride Capsules

Product Name
盐酸雷尼替丁胶囊
Approval Number
国药准字H64020217
Approval Date
Dec 18, 2019
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 33
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.